Comparison Chart Omnicell, Inc. Deutsche Boerse AG
Stocks
OC9
US68213N1090
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
01:30:33 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 28.20 EUR | +1.44% |
|
-0.71% | -28.35% |
| 09-03 | Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations | CI |
| 08-14 | US Physical Therapy Names Nchacha Etta as Chief Financial Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OMNICELL, INC. | Medical Software & Technology Services | -1.42% | -0.71% | -28.35% | +6.11% | -79.25% | 1.47B |
-
|
-
|
-
|
- Stock Market
- Stocks
- OMCL Stock
- OC9 Stock
- Charts Omnicell, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
